Showing results (111-120 of 156) with videos related to
Sort By:
Pageof 16
Journal of Orthopaedic Science : Official Journal of the Japanese Orthopaedic Association|August 22, 2015
Opportunities for improvement: anticoagulation in patients undergoing total knee or hip replacementMads Thorsberger, Thomas Jensen, Jonas Olesen, et al.Clinical Endocrinology|July 14, 2019
Clinical prediction score of nonalcoholic fatty liver disease in adolescent girls with polycystic ovary syndrome (PCOS-HS index)Anne-Marie Carreau, Laura Pyle, Yesenia Garcia-Reyes, et al.Bioorganic & Medicinal Chemistry Letters|December 3, 2014
The identification of GPR3 inverse agonist AF64394; the first small molecule inhibitor of GPR3 receptor functionThomas Jensen, Lisbeth Elster, Søren Møller Nielsen, et al.Plos One|February 19, 2015
Development and blind clinical validation of a microRNA based predictor of response to treatment with R-CHO(E)P in DLBCLSteen Knudsen, Christoffer Hother, Kirsten Grønbæk, et al.Journal of Biomedical Materials Research. Part A|August 21, 2010
Hydroxyapatite nanoparticles in poly-D,L-lactic acid coatings on porous titanium implants conducts bone formationThomas Jensen, Thomas Jakobsen, Jørgen Baas, et al.Colloids and Surfaces. B, Biointerfaces|September 29, 2009
Interaction of human mesenchymal stem cells with osteopontin coated hydroxyapatite surfacesThomas Jensen, Alireza Dolatshahi-Pirouz, Morten Foss, et al.Plos One|May 13, 2016
Cell Line Derived 5-FU and Irinotecan Drug-Sensitivity Profiles Evaluated in Adjuvant Colon Cancer Trial DataIda Kappel Buhl, Sarah Gerster, Mauro Delorenzi, et al.Journal of Gastroenterology|August 20, 2016
Advances in the diagnosis and treatment of pancreatic neuroendocrine neoplasms in JapanTetsuhide Ito, Susumu Hijioka, Toshihiko Masui, et al.Metabolism Open|August 20, 2020
Nonalcoholic fatty liver disease in obese adolescent females is associated with multi-tissue insulin resistance and visceral adiposity markersMelanie Cree-Green, Sonalee Ravi, Anne-Marie Carreau, et al.Plos One|March 23, 2018
Molecular prediction of adjuvant cisplatin efficacy in Non-Small Cell Lung Cancer (NSCLC)-validation in two independent cohortsIda Kappel Buhl, Eric Santoni-Rugiu, Jesper Ravn, et al.Pageof 16